Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial. Bragagnoli AC, Araujo RLC, Ferraz MW, Dos Santos LV, et al. Br J Cancer 2021 Jan 4. pii: 10.1038/s41416-020-01208.

Read + Share

Amedeo Smart

Independent Medical Education

Bragagnoli AC, Araujo RLC, Ferraz MW, Dos Santos LV, et al. Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial. Br J Cancer 2021 Jan 4. pii: 10.1038/s41416-020-01208.
PMID: 33398062